The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Epithelial to mesenchymal transition in head and neck squamous carcinoma: Association of Src activation with E‐cadherin down‐regulation, vimentin expression, and aggressive tumor features
Open accessAbstract
BACKGROUND: Epithelial–mesenchymal transformations (EMT) are critical for the invasion, progression, and metastasis of epithelial carcinogenesis. The role of EMT in head and neck squamous carcinoma (HNSC) tumorigenesis remains unexplored. In the current study, the expressions of several factors associated with the induction of EMT in HNSC cell lines and tumor specimens were investigated to define their functional and pathologic role in HNSC. METHODS: Eleven HNSC cell lines and 50 primary tumor tissue specimens formed the materials of this study. Western blot analysis as well as immunohistochemical, and functional techniques were used to assess the status of activated Src (p‐Src), E‐cadherin, and vimentin in both cell lines and tumor tissues and the results were correlated with patients' clinicopathologic parameters. RESULTS: The results demonstrated the inverse expression of p‐Src and E‐cadherin in the majority of cell lines and in primary tumor tissues compared with normal squamous mucosa. Elevated levels of p‐Src were accompanied by down‐regulation of E‐cadherin and the expression of vimentin in epithelial tumor cells. In vitro inhibition of Src led to E‐cadherin reexpression and increased cell contact in squamous carcinoma cell lines. Immunophenotypic analysis of these markers in primary tumor tissues demonstrated a significant correlation between increased p‐Src, decreased E‐cadherin, and vimentin expression and aggressive tumor features including penetrating invasive fronts, high‐grade sarcomatoid transformation, and lymph node metastasis. CONCLUSIONS: The results of the current study indicate that Src and E‐cadherin may play an important role in EMT, invasion, and aggressive clinicopathologic features of HNSC. These proteins may be targeted for the therapeutic intervention of patients with HNSC. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
Cited by
Src signaling in cancer invasion
Guarino, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22011 · Cited by 426
Sabbah, M., Emami, S., Redeuilh, G., Julien, S., Prévost, G., Zimber, A., Ouelaa, R., Bracke, M., De Wever, O., & Gespach, C. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.07.001 · Cited by 322
Chaw, S. Y., Abdul Majeed, A., Dalley, A. J., Chan, A., Stein, S., & Farah, C. S. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.05.011 · Cited by 302
Soltermann, A., Tischler, V., Arbogast, S., Braun, J., Probst-Hensch, N., Weder, W., Moch, H., & Kristiansen, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0935 · Cited by 269
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
Araujo, J., & Logothetis, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.015 · Cited by 244
Metadata
- Authors
- Mandal, M., Myers, J. N., Lippman, S. M., Johnson, F. M., Williams, M. D., Rayala, S., Ohshiro, K., Rosenthal, D. I., Weber, R. S., Gallick, G. E., & El‐Naggar, A. K.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-04-21
- Volume
- 112
- Issue
- 9
- Pages
- 2088-2100
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1559021784
- Cited by
- 204
- References
- 2
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epithelial to mesenchymal transition in head and neck squamous carcinoma: Association of Src activation with E‐cadherin down‐regulation, vimentin expression, and aggressive tumor features. https://app.cochat.ai/papers/10.1002/cncr.23410
- The paper
- Mandal, M., Myers, J. N., Lippman, S. M., Johnson, F. M., Williams, M. D., Rayala, S., Ohshiro, K., Rosenthal, D. I., Weber, R. S., Gallick, G. E., & El‐Naggar, A. K. (2008). Epithelial to mesenchymal transition in head and neck squamous carcinoma: Association of Src activation with E‐cadherin down‐regulation, vimentin expression, and aggressive tumor features. Cancer. https://doi.org/10.1002/cncr.23410
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.